Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction.

van Diepen S, Vavalle JP, Newby LK, Clare R, Pieper KS, Ezekowitz JA, Hochman JS, Mahaffey KW, Armstrong PW, Granger CB.

Crit Care Med. 2013 Sep;41(9):2080-7. doi: 10.1097/CCM.0b013e31828a67b2.

PMID:
23760155
2.

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW.

Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.

4.

Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.

Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L.

Kardiol Pol. 2013;71(3):260-7. doi: 10.5603/KP.2013.0038.

5.

Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.

Guptill JT, Mehta RH, Armstrong PW, Horton J, Laskowitz D, James S, Granger CB, Lopes RD.

Circ Cardiovasc Interv. 2013 Apr;6(2):176-83. doi: 10.1161/CIRCINTERVENTIONS.112.000159. Epub 2013 Apr 2.

6.

Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock.

Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS; SHOCK Investigators.

Arch Intern Med. 2005 Jul 25;165(14):1643-50.

PMID:
16043684
7.

Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study.

Shiomi H, Nakagawa Y, Morimoto T, Furukawa Y, Nakano A, Shirai S, Taniguchi R, Yamaji K, Nagao K, Suyama T, Mitsuoka H, Araki M, Takashima H, Mizoguchi T, Eisawa H, Sugiyama S, Kimura T; CREDO-Kyoto AMI investigators.

BMJ. 2012 May 23;344:e3257. doi: 10.1136/bmj.e3257.

PMID:
22623632
8.

Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.

De Luca G, Gibson CM, Huber K, Zeymer U, Dudek D, Cutlip D, Bellandi F, Noc M, Emre A, Zorman S, Gabriel HM, Maioli M, Rakowski T, Gyöngyösi M, Van't Hof AW; EGYPT Cooperation.

Am Heart J. 2009 Sep;158(3):416-21. doi: 10.1016/j.ahj.2009.06.029.

PMID:
19699865
9.

Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).

Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW.

Am J Cardiol. 2007 Jul 15;100(2):206-10. Epub 2007 Jun 4.

PMID:
17631071
10.

Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction.

Glickman SW, Cairns CB, Chen AY, Peterson ED, Roe MT.

Am Heart J. 2010 Jun;159(6):998-1004.e2. doi: 10.1016/j.ahj.2010.03.022.

PMID:
20569712
11.

Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.

Maas AC, Wyatt CM, Green CL, Wagner GS, Trollinger KM, Pope JE, Langer A, Armstrong PW, Califf RM, Simoons ML, Krucoff MW.

Am Heart J. 2004 Apr;147(4):698-704.

PMID:
15077087
12.

Benefit of immediate beta-blocker therapy on mortality in patients with ST-segment elevation myocardial infarction.

Hirschl MM, Wollmann CG, Erhart F, Brunner W, Pfeffel F, Gattermeier M, Steger F, Mayr H.

Crit Care Med. 2013 Jun;41(6):1396-404. doi: 10.1097/CCM.0b013e31827caa64.

PMID:
23528803
13.

Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.

Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P; Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators.

Circulation. 2003 Dec 9;108(23):2851-6. Epub 2003 Nov 17.

14.

Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI).

Brener SJ, Mehran R, Dressler O, Cristea E, Stone GW.

Am J Cardiol. 2012 Apr 15;109(8):1111-6. doi: 10.1016/j.amjcard.2011.11.046. Epub 2012 Jan 13.

PMID:
22244381
15.

Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction.

Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Müller-Bardorff M, Richardt G, Katus HA.

Crit Care Med. 2002 Oct;30(10):2229-35.

PMID:
12394949
16.

Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.

Samimi-Fard S, Dominguez-Rodriguez A, Abreu-Gonzalez P, Enjuanes-Grau C, Blanco-Palacios G, Hernandez-Baldomero IF, Bosa-Ojeda F, Marrero-Rodríguez F.

Am J Cardiol. 2009 Sep 1;104(5):634-7. doi: 10.1016/j.amjcard.2009.04.049. Epub 2009 Jun 24.

PMID:
19699336
18.

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.

Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E.

J Am Coll Cardiol. 2004 Jul 21;44(2):335-9.

19.

Prognostic impact of Q waves on presentation and ST resolution in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Kumar S, Hsieh C, Sivagangabalan G, Chan H, Ryding AD, Narayan A, Ong AT, Sadick N, Kovoor P.

Am J Cardiol. 2009 Sep 15;104(6):780-5. doi: 10.1016/j.amjcard.2009.05.007.

PMID:
19733711
20.

Deadly association of cardiogenic shock and chronic total occlusion in acute ST-elevation myocardial infarction.

Bataille Y, Déry JP, Larose É, Déry U, Costerousse O, Rodés-Cabau J, Gleeton O, Proulx G, Abdelaal E, Machaalany J, Nguyen CM, Noël B, Bertrand OF.

Am Heart J. 2012 Oct;164(4):509-15. doi: 10.1016/j.ahj.2012.07.008.

PMID:
23067908

Supplemental Content

Support Center